| Issue | Title | |
| Vol 12 (2010) | 2010 National Summit on HIV Diagnosis, Prevention and Access to Care: Abstract Table of Contents | Abstract PDF |
| FCHR HIV Forum Proceedings | ||
| Vol 12 (2010) | 2010 National Summit on HIV Diagnosis, Prevention and Access to Care: Authors Index | Abstract PDF |
| FCHR HIV Forum Proceedings | ||
| Vol 12 (2010) | 2010 National Summit on HIV Diagnosis, Prevention and Access to Care: Summit Committee | Abstract PDF |
| FCHR HIV Forum Proceedings | ||
| Vol 12 (2010) | 2010 National Summit on HIV Diagnosis, Prevention and Access to Care: Summit Program | Abstract PDF |
| FCHR HIV Forum Proceedings | ||
| Vol 12 (2010) | 2010 National Summit on HIV Diagnosis, Prevention and Access to Care: Track A Abstracts | Abstract PDF |
| FCHR HIV Forum Proceedings | ||
| Vol 12 (2010) | 2010 National Summit on HIV Diagnosis, Prevention and Access to Care: Track B Abstracts | Abstract PDF |
| FCHR HIV Forum Proceedings | ||
| Vol 12 (2010) | 2010 National Summit on HIV Diagnosis, Prevention and Access to Care: Track C Abstracts | Abstract PDF |
| FCHR HIV Forum Proceedings | ||
| Vol 12 (2010) | 2010 National Summit on HIV Diagnosis, Prevention and Access to Care: Track D Abstracts | Abstract PDF |
| FCHR HIV Forum Proceedings | ||
| Vol 9 (2007) | A NEW ERA FOR HIV PREVENTION? | Abstract PDF |
| Chris Collins, Meagan Lyon, Veronica Miller | ||
| Vol 10 (2008) | ARV DRUGS, ADVERSE EVENTS, CASE DEFINITION, GRADING, LABORATORY DIAGNOSIS AND TREATMENT MONITORING | Abstract PDF |
| Veronica Miller | ||
| Vol 3 (2000) | BONE METABOLISM AND HIV DISEASE MEETING REPORT | Abstract PDF HTML |
| Lawrence Raisz, Jane Aubin, Veronica Miller | ||
| Vol 7 (2005) | BUPRENORPHINE AND PRIMARY HIV CARE | Abstract PDF HTML |
| Jeanine Warden, Craig Hunter, Veronica Miller | ||
| Vol 6 (2003) | CARDIOVASCULAR RISK IN HIV INFECTION AND TREATMENT | Abstract PDF |
| Mark Mascolini, Veronica Miller | ||
| Vol 14, No 2 (2012) | Clinically Relevant HCV Drug Resistance Mutations Figure and Tables (In Revision) | Details PDF |
| HCV Phenotype Working Group, HCV Drug Development Advisory Group | ||
| Vol 14, No 3 (2012) | Clinically Relevant HCV Drug Resistance Mutations Figure and Tables (Updated) | Details PDF |
| HCV Phenotype Working Group, HCV Drug Development Advisory Group | ||
| Vol 9 (2007) | COLLABORATIVE APPROACHES TO HIV DRUG DEVELOPMENT: PLANNING FOR LONG-TERM MONITORING OF SAFETY IN CCR5 ANTAGONIST DEVELOPMENT | Abstract PDF HTML |
| John Fry, Johanna Bogulavsky Grossman, Veronica Miller | ||
| Vol 1, No 2 (1998) | DISSEMINATION AND EVALUATION OF CLINICAL PRACTICE GUIDELINES FOR HIV | Abstract PDF |
| Tina Sogocio, David Barr | ||
| Vol 11 (2009) | EVALUATION OF IMPACT OF ADULT MALE CIRCUMCISION PROGRAMS ON HIV INCIDENCE AND PREVALENCE: CURRENT RESEARCH, GAPS IN KNOWLEDGE AND RECOMMENDATIONS FOR ADDITIONAL RESEARCH | Abstract PDF HTML |
| Sarah Kim, Shrimant Mishra, Veronica Miller | ||
| Vol 4 (2001) | EXAMINING THE RISK AND BENEFITS OF DIRECTLY OBSERVED THERAPY FOR TREATMENT OF HIV DISEASE | Abstract PDF |
| Karen Eddelman | ||
| Vol 2 (1999) | FAILURE OF INITIAL ANTIRETROVIRAL TREATMENT REGIMENS | Abstract PDF |
| David Gilden | ||
| Vol 1, No 2 (1998) | FCHR PROJECT ON METABOLIC ABNORMALITIES IN HIV DISEASE AND TREATMENT: THE NEED FOR AN INTERIM CASE DEFINITION AND A STUDY TO EXAMINE PREVALENCE | Abstract PDF |
| Susan Brobst | ||
| Vol 6 (2003) | FORUM FOR COLLABORATIVE HIV RESEARCH SUMMARY OF THE EXECUTIVE COMMITTEE RETREAT | Abstract PDF |
| Veronica Miller | ||
| Vol 13, No 1 (2011) | HIV Clinic Capacity and Medical Workforce Challenges: Results of a Survey of Ryan White Part C-funded Programs | Abstract PDF |
| Benjamin C. Hauschild, Andrea Weddle, Jenny K. Tegelvik, Christine Lubinski, Veronica Miller, Michael S. Saag | ||
| Vol 1, No 2 (1998) | HIV TREATMENT FAILURE: A REVIEW OF CURRENT CLINICAL RESEARCH | Abstract PDF |
| Mark Harrington, Julia Hidalgo | ||
| Vol 9 (2007) | HIV-TB CO-INFECTION: MEETING THE CHALLENGE | Abstract PDF HTML |
| Nyasha Bakare, Veronica Miller | ||
| 1 - 25 of 60 Items | 1 2 3 > >> | |
The Forum for Collaborative HIV Research